Stock Market

Tattooed Chef (TTCF): Plant-based food company Tattooed Chef is expecting slower sales growth and significant operating costs. Weber (WEBR): Weber has been negatively affected by the volatility of broader markets and its disappointing performance. Canoo (GOEV): Reddit’s WallStreetBets community helped Canoo thrive after a dip in the share price. However, the short investors who got
0 Comments
[embedded content] In this week’s episode, Aaron and I discuss the market’s most major recent developments, including re-assessing my bull thesis on QuantumScape (NYSE:QS) stock. As it stands, the long-term thesis remains intact for QuantumScape stock. While electric cars and EV charging stocks remain in focus in the here and now, we can’t talk EVs
0 Comments
PayPal (PYPL) recently laid off its next-gen tech team, raising questions about its relevance The move highlights the confusing nature of PYPL stock, both fundamentally and technically Conservative investors should tread carefully with PYPL stock Source: Michael Vi / Shutterstock.com PayPal (NASDAQ:PYPL) disclosed last week that it laid off its research team focused on advanced
0 Comments
In the last 30 days, Moderna (NASDAQ:MRNA) stock is up nearly 11%. That’s welcome news to investors who bought shares prior to the selloff that started in September. At that time, MRNA stock was trading above $450 per share. However, for many reasons, Moderna is not likely to move significantly higher anytime soon. For that
0 Comments
Bank of America (BAC) is hoping an earnings win can turn a rough year around. Charles Schwab (SCHW) has used its innovation to fare better than most so far in 2022. Johnson & Johnson (JNJ) has outperformed in 2022, and an earnings beat could push it higher. Netflix (NFLX) needs to show stronger growth to keep investors happy.
0 Comments
Novavax (NVAX) lost the COVID vaccine race to Moderna and Pfizer. Profits are only now starting to roll in. NVAX stock looks fairly-valued. Source: rarrarorro / Shutterstock.com Novavax (NASDAQ:NVAX) is finally making money from Covid-19, but no one cares about NVAX stock anymore. A profit of about $200 million, $3.30 per share, is expected when
0 Comments
Gevo (NASDAQ:GEVO) is developing renewable electricity and renewable natural gas for production processes, which has helped thrust GEVO stock into the spotlight. The company states that its “products perform as well or better than traditional fossil-based fuels in infrastructure and engines, but with substantially reduced greenhouse gas emissions.” Gevo says its technology can also be
0 Comments
Deutsche Bank analyst Emmanuel Rosner initiated coverage of QuantumScape (NYSE:QS) on April 12 with a Hold rating and a $20 target price for QS stock.  While the analyst has significant doubts about the company’s ability to scale its solid-state lithium metal battery technology, the fact that his target price provides some upside in the months
0 Comments
Shares of consumer products company Aterian (NASDAQ:ATER), formerly known as Mohawk Group, shot up 24% Tuesday to close at $5 a share. Source: studiostoks / Shutterstock.com Aterian’s business model is to sell a variety of consumer products through e-commerce channels. It claims to have artificial intelligence that helps it automate and drive performance for various
0 Comments
Microsoft (NASDAQ:MSFT) stock tumbled on Monday after Karl Keirstead of UBS suggested that Office 365 growth could soften as the “work-from-home” benefits are starting to fade. Keirstead suggested that UBS analysts “now believe that it is prudent to begin modeling a gentle deceleration in commercial Office 365 seat growth given the combo of the pandemic/work-from-home boost fading and
0 Comments